In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination - Concepedia

Concepedia

Publication | Open Access

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination

DOI Full Paper Access

99

Citations

35

References

2017

Year

Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, Dan Elwood, Benjamin D. McElvany, Ellen A. Fraser, Marya P. Carmolli, Cecilia Tibery, Noreen A. Hynes, Matthew Jo,

PLoS neglected tropical diseases

Abstract

ClinicalTrials.gov NCT01506570.

References

	Year	Citations

Page 1